-
2022-502442-27-00
5
2024-01-08
Obesity
-
2022-502779-40-00
5
2023-09-04
Primary prevention of atherosclerotic cardiovascular disease (ASCVD)
-
2022-501419-15-00
5
2023-08-23
Atrial Fibrillation
-
2022-501176-26-00
5
2023-08-04
Acute Ischemic Stroke and High-Risk Transient Ischemic Attack
-
2022-501608-85-00
5
2023-05-09
Cardiovascular disease (atherosclerotic cardiovascular disease (ASCVD)
-
2024-510818-33-00
5
2023-01-24
Chronic Spontaneous Urticaria
-
2022-501744-15-00
5
2023-01-23
Obesity, Overweight
-
2024-512120-11-00
7
2022-08-31
Part 2A, 2B, 2C & 2E
HR-positive /HER2-negative breast cancer
-
2024-510735-21-00
5
2021-11-26
Atherosclerotic cardiovascular disease (ASCVD)
-
2023-506926-35-00
5
2021-09-24
Atherosclerotic cardiovascular disease, chronic kidney disease and sys
-
2022-501645-70-00
5
2020-11-25
Crohns Disease
-
2022-502841-91-00
5
2020-08-12
Crohn’s Disease
-
2023-508292-37-00
5
2020-03-06
Cardiovascular Disease
-
2022-502937-24-00
5
2019-01-02
Atopic Dermatitis
-
2023-506994-36-00
5
2018-10-11
Ulcerative Colitis
-
2023-505699-31-00
5
2017-01-02
Ulcerative Colitis
-
2023-504678-39-00
4
2024-03-13
Heart Failure
-
2022-501418-69-00
5
2023-11-21
Acute Coronary Syndrome
-
2023-510446-24-00
4
2023-05-30
Cancer cachexia
-
2023-503794-38-00
5
2022-11-24
Prevention of stroke or systemic embolism in atrial fibrillation
-
2024-510612-75-00
5
2022-08-31
Participants with T2D and overweight
-
2023-505786-88-00
5
2021-04-25
Severe and inadequately controlled asthma
-
2023-507846-96-00
5
2020-06-19
Type 2 Diabetes Mellitus
-
2023-503673-38-00
5
2019-05-24
Adults at high risk of cardiovascular events without prior MI or strok